Predicting outcomes for Crohn's disease using a molecular biomarker: profile trial.

Noor, Nurulamin; Brezina, Biljana; Negro, Juan De La Revilla; Dowling, Francis; Bond, Simon; Whitehead, Lynne; Lee, Jacinta; Lyons, Paul; McKinney, Eoin; Smith, Kenneth; Lee, James; Parkes, Miles

Noor, Nurulamin; Brezina, Biljana; Negro, Juan De La Revilla; Dowling, Francis; Bond, Simon; Whitehead, Lynne; Lee, Jacinta; Lyons, Paul; McKinney, Eoin; Smith, Kenneth; Lee, James; Parkes, Miles.

Afiliación

Noor N; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Brezina B; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Negro JR; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Dowling F; Cambridge Clinical Trials Unit, Cambridge, UK.
Bond S; Cambridge Clinical Trials Unit, Cambridge, UK.
Whitehead L; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Lee J; University of Cambridge School of Clinical Medicine, Cambridge, UK.
Lyons P; University of Cambridge School of Clinical Medicine, Cambridge, UK.
McKinney E; University of Cambridge School of Clinical Medicine, Cambridge, UK.
Smith K; University of Cambridge School of Clinical Medicine, Cambridge, UK.
Lee J; The Francis Crick Institute, London, UK.
Parkes M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Clin Med (Lond) ; 22(Suppl 4): 22-23, 2022 07.

Article en En | MEDLINE | ID: mdl-36220241

Asunto(s)

Enfermedad de Crohn; Biomarcadores; Enfermedad de Crohn/diagnóstico; Enfermedad de Crohn/tratamiento farmacológico; Humanos; Inducción de Remisión

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Crohn Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Med (Lond) Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google